XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadnejad D, Tayefi-nasrabadi H, Naghibi M, Abedelahi A. Cetrorelix preserves follicular viability in Cyclophosphamid-induced ovarian toxicity. Journal of Research in Applied and Basic Medical Sciences 2015; 1 (1) :56-60
URL: http://ijrabms.umsu.ac.ir/article-1-41-en.html
Department of Anatomical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran , abedelahia@yahoo.com
Abstract:   (4339 Views)

Received 7 May 2015, accepted for publication 29 July 2015

Background & Aims: Anticancer drugs are known to have great impact on spermatogenesis process and germinal epithelium. The present study is to investigate the preventive effect of Cetrorelix (GnRH antagonist) on Cyclophosphamide- induced spermatogenic defect.

Methods and Materials: Fifty adult female mice aging 6-8 weeks (30±4 gr) were divided into 3 groups as: Control, Experimental 1 and Experimental 2. The animals in Experimental 1 group received Cyclophosphamide (2.5 mg/kg, ip) for 5 days and in Experimental 2 group received Cetrorelix (0.25 mg/kg, ip) one week before Cyclophosphamide treatment and continued for 3 weeks. The mice in all groups were sacrificed 35 days after the last injection. Ovarian follicles were isolated mechanically and the viability was studied by trypan blue staining.

Results: Ovarian follicles of animals in Experimental 2group, retained higher percentage of normal morphology (P<0.001) than which in Experimental 1 group and their condition were similar to control group.

Conclusion: These results indicate that the Cetrorelix administration before cancer treatment may protect ovarian tissue against side effects of cisplatin.

Keywords: Ovarian follicles, Viability, GnRH antagonist, Cetrorelix

Full-Text [PDF 108 kb]   (943 Downloads)    
Type of Study: orginal article | Subject: Special

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Research in Applied and Basic Medical Sciences

Designed & Developed by : Yektaweb